Rambam HCC and Georgia Institute of Technology Establish Accelerator for Israeli Medical Technologies in Atlanta, Georgia
Rambam HCC and Georgia Institute of Technology Establish Accelerator for Israeli Medical Technologies in Atlanta, Georgia On October 11, 2018 a memorandum of understanding was signed for cooperation between Rambam Health Care Campus and the Global Center for Medical Innovation (GCMI) at Georgia’s Institute of Technology at a special ceremony held in Atlanta, Georgia. The outcome of this partnership will be a medical technology incubator for Israeli-based companies. This cooperative effort was made possible thanks to the assistance of the Israeli consulate in the southeastern United States and the America-Israel Chamber of Commerce (CONEX). The incubator will focus on advancing innovation in the field of biomedical and digital medicine, and will offer selected companies financing, accompanying business mentors in the US market, product development and commercialization assistance, and help in establishing relationships with strategic partners and potential investors. The initiation track will continue between six months and one year, according to a pre-determined plan. A GCMI will be stationed at Rambam, to help with selecting appropriate companies to take part in the venture. GCMI will be responsible for management of the technology accelerator. The ceremony was attended by Rambam’s director, Professor Rafi Beyar, Advocate Ronia Rubinstein, Director of Rambam Research Unit. The event was also attended by Tiffany Wilson, CEO of GCMI, Ambassador Yehudit Varnay Shorer, Israel's Consul General in the Southeastern United States, Guy Tessler, Director General of the American Israel Chamber of Commerce, Brentley, Hala Modalmog, Director of the Atlanta Chamber of Commerce, and more. "GCMI has great expertise in leading medical device and digital health products from concept through to planning, production, pre-clinical, etc., to regulatory approval and sales," explains Rubinstein. Explaining how the cooperation will work, she continues, “From day one, we can benefit from their knowledge regarding regulatory requirements and the unique business practices in the USA. We will benefit their knowledge and embark on the path Israeli companies must follow, a process that will primarily take place Israel, but will reach Atlanta for product promotion, recruiting investors, and more." According to Professor Beyar, this is good news for Israel in general, and Haifa in particular: “Both sides, Israel and Atlanta, will profit,” says Beyar, “We will profit from the knowledge and experience gained in the global center and to enable Israeli technology to transform from local to international industry," explains Prof. Beyar. “We can benefit greatly from the depth of knowledge and experience gained by the global center, to transform Israeli technology from the local to international industry. Our US partners have access to Israeli innovation and will be able to harness it for the benefit of consumers in the USA. This is the beginning of a fruitful and exciting partnership."
In the Picture (L-R): Hala Modalmog, Director of the Atlanta Chamber of Commerce; Tiffany Wilson, Executive Director of the Global Center for Medical Innovation (GCMI); Professor Rafi Beyar, Director of Rambam Health Care Campus; Advocate Ronya Rubinstein;
Copyright @2018 Australian Friends of Rambam Medical Center. All rights reserved.